Roche Sales Boosted By Demand For Tamiflu

Swiss drugmaker Roche has posted strong results in the first nine months of 2009, highlighting the opportunities that pandemics such as the current A (H1N1) 2009 influenza virus ('swine flu') outbreak can provide drug companies. The company has reported a 9.3% rise increase in year-on-year (y-o-y) revenues, from US$32.72bn in January-September 2008 to US$35.76bn in January-September 2009. It has also raised its 2009 sales forecast as more people buy its drug Tamiflu (oseltamivir), used to treat pandemic influenza. BMI notes that in 2008, sales of Tamiflu had

To read the full article, please choose one of the following options: